This insight brief explores the growing role of patient perspectives in Health Technology Assessment (HTA) and medicines access decisions. IQVIA analyzes how consumer input and consumer-generated evidence are incorporated into HTA submissions across Australia, Canada, France, Germany, and the United Kingdom. The report finds that Australia performs strongly in encouraging patient participation but lags behind peer markets in leveraging formal consumer evidence. It highlights emerging policy reforms designed to improve patient engagement, transparency, and evidence integration within Australia's HTA framework. The brief concludes that stronger collaboration between industry, patient advocacy groups, and policymakers can help ensure healthcare decisions better reflect patient experiences, ne

Join for free to read